TESTOSTERONE PELLET 200 mg BLUNT recall — Class II (D-0416-2025) · pharmaranks
Class IIOngoing
TESTOSTERONE PELLET 200 mg BLUNT recall
FDA recall D-0416-2025 · initiated Apr 28, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Particulate Matter: Glass particles were found in pellet vials.
Details
Product
TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01
Recalling company
BSO LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Apr 28, 2025
FDA report date
May 14, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.